FDA Inspection
United Exchange CorporationUnited Exchange Corporation – FDA Inspection, Apr 6, 2018
Record Details
This FDA Inspection record concerns United Exchange Corporation, with an inspection on April 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c06c4134-5adb-403c-9d8c-cc6619cdbb78
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1047420
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
4- 21 CFR 211.165(d)Acceptance criteria for sampling & testing
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of United Exchange Corporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2018 | VAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for United Exchange Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.